Literature DB >> 10485325

Increased tyrosine phosphorylation of the insulin receptor, the insulin receptor substrate-1 and a 73 kDa protein associated with insulin-induced mitogenesis in SV40-transformed 3T3T cells.

H Wang1.   

Abstract

Insulin selectively induces mitogenesis in quiescent SV40 large T antigen-transformed murine 3T3T (CSV3-1) cells but not in quiescent nontransformed 3T3T cells. This mitogenic effect induced by insulin in CSV3-1 cells requires an induction of AP-1 activity associated with c-Jun and JunB. To further investigate the mechanisms that are involved in insulin-induced mitogenesis in CSV3-1 cells, the current experiments were performed. The results show that following insulin stimulation, the insulin receptor beta-subunit and the insulin receptor substrate-1 undergo a much more significant tyrosine phosphorylation in CSV3-1 cells than in 3T3T cells. Insulin also induces tyrosine phosphorylation of a 73 kDa protein that is coprecipitated with the tyrosine-phosphorylated insulin receptor in CSV3-1 cells but not in 3T3T cells. The increased tyrosine phosphorylation in response to insulin stimulation in CSV3-1 cells does not appear to be due to an increase in the level of expression of the insulin receptor and does not appear to result from a significant change in tyrosine phosphatase activity compared to nontransformed cells. The results also show that the insulin effect in CSV3-1 cells is not mediated by insulin-like growth factor 1 receptor because insulin at the concentrations that induce mitogenesis does not increase the tyrosine phosphorylation of the insulin-like growth factor 1 receptor and the expression level of the receptor is not significantly changed in CSV3-1 cells compared to nontransformed cells. These data together indicate that the selective mitogenic effect of insulin on CSV3-1 cells involves increased tyrosine phosphorylation of the insulin receptor, the insulin receptor substrate-1 and the 73 kDa protein, although the underlying mechanisms need to be further elucidated.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10485325     DOI: 10.1023/a:1006937720559

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  38 in total

1.  Insulin-induced mitogenesis associated with transformation by the SV40 large T antigen.

Authors:  H L Wang; R E Scott
Journal:  J Cell Physiol       Date:  1991-04       Impact factor: 6.384

Review 2.  The IRS-signalling system during insulin and cytokine action.

Authors:  L Yenush; M F White
Journal:  Bioessays       Date:  1997-06       Impact factor: 4.345

Review 3.  Signal transmission by the insulin-like growth factors.

Authors:  M P Czech
Journal:  Cell       Date:  1989-10-20       Impact factor: 41.582

Review 4.  Insulin signal transduction and the IRS proteins.

Authors:  M G Myers; M F White
Journal:  Annu Rev Pharmacol Toxicol       Date:  1996       Impact factor: 13.820

5.  A cascade of tyrosine autophosphorylation in the beta-subunit activates the phosphotransferase of the insulin receptor.

Authors:  M F White; S E Shoelson; H Keutmann; C R Kahn
Journal:  J Biol Chem       Date:  1988-02-25       Impact factor: 5.157

Review 6.  The insulin signaling system.

Authors:  M F White; C R Kahn
Journal:  J Biol Chem       Date:  1994-01-07       Impact factor: 5.157

7.  Distinct protein tyrosine phosphorylation during mitogenesis induced in quiescent SV40-transformed 3T3 T cells by insulin or vanadate.

Authors:  H Wang; R E Scott
Journal:  J Cell Physiol       Date:  1994-03       Impact factor: 6.384

Review 8.  Protein-tyrosine phosphatases.

Authors:  R L Stone; J E Dixon
Journal:  J Biol Chem       Date:  1994-12-16       Impact factor: 5.157

Review 9.  The insulin receptor. A multifunctional protein.

Authors:  J M Olefsky
Journal:  Diabetes       Date:  1990-09       Impact factor: 9.461

10.  Stat5 is a physiological substrate of the insulin receptor.

Authors:  J Chen; H B Sadowski; R A Kohanski; L H Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.